middle.news
How Orthocell’s Remplir Could Transform Prostate Surgery Recovery Worldwide
9:16am on Tuesday 16th of September, 2025 AEST
•
Healthcare
Read Story
How Orthocell’s Remplir Could Transform Prostate Surgery Recovery Worldwide
9:16am on Tuesday 16th of September, 2025 AEST
Key Points
Remplir used in ~40 nerve-sparing robotic prostate surgeries in Australia
Targets reduction of erectile dysfunction and urinary incontinence post-surgery
Orthocell collecting clinical data and planning further research
Strategic alignment with da Vinci Surgical System distributor supports rollout
Read Story
middle.
Tap to Read
Tap the card to read the full analysis
about
Orthocell (ASX:OCC)
OPEN ARTICLE